Related Experiment Videos
Method for measuring endogenous 3-O-methyldopa in urine and plasma
I Armando1, E Grossman, A Hoffman
1Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Journal of Chromatography
|July 17, 1991
Summary
This study presents a new method for measuring 3-O-methyldopa in urine and plasma using liquid chromatography. This technique accurately quantifies 3-O-methyldopa, aiding research into DOPA metabolism.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Pharmacology
Background:
- 3-O-methyldopa (3-OMD) is a metabolite of L-DOPA.
- Accurate quantification of 3-OMD is crucial for understanding L-DOPA metabolism and its clinical implications.
Purpose of the Study:
- To develop and validate a sensitive method for assaying 3-O-methyldopa concentrations in biological samples.
- To establish reference ranges for urinary and plasma 3-OMD in healthy individuals.
Main Methods:
- Column liquid chromatography with electrochemical detection.
- One-step sample preparation with post-column flow-through electrodes.
- Validation using animal models and correlation studies in humans.
Main Results:
- The method achieved adequate chromatographic separation of 3-OMD from endogenous substances.
- Validation confirmed method accuracy through animal studies and human correlation analyses.
- In healthy humans, average urinary excretion was 974 ± 707 nmol/day and plasma levels were 89 ± 32 nmol/l.
Conclusions:
- The developed method is reliable for quantifying 3-O-methyldopa in urine and plasma.
- This assay can be valuable for research into the metabolism of endogenous and exogenous DOPA.
- Findings provide baseline data for 3-OMD levels in healthy populations.